TY - GEN
T1 - Novel Ex Vivo Continuous Hypothermic Cardiac Preservation Machine in Swine Slaughterhouse Model
AU - Ngamdachakij, P.
AU - Prayadrat, C.
AU - Kiattimongkol, N.
AU - Chumsunthorn, N.
AU - Sacharoen, A.
AU - Diloksumpan, P.
AU - Gesprasert, G.
AU - Naiyanetr, P.
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2026.
PY - 2026
Y1 - 2026
N2 - Effective heart preservation is a critical determinant of transplant success. However, current techniques limit the allowable ischemic interval to four hours. A novel ex vivo continuous hypothermic cardiac preservation machine was developed at Mahidol University. This study evaluates the unoxygenated hypothermic machine perfusion (HMP) method by examining cardiac troponin I (cTnI) release as a marker of myocardial injury. Ten slaughterhouse porcine hearts—representing a donor after circulatory death (DCD) model—were randomized to Static Cold Storage (SCS) or HMP (n = 5/group). An in-house Histidine-Tryptophan-Ketoglutarate (HTK) solution served as both cardioplegic agent and perfusate. SCS followed gold-standard protocol, while HMP involved continuous retrograde perfusion at 13 mmHg; both groups were preserved under cold ischemic preservation at 4 degrees Celsius. Perfusate samples were collected at 0, 1, 2, 3, and 4 hours, and cTnI values were normalized to heart weight (cTnI/W). A mixed-effects model was used to analyze temporal changes. Final cTnI/W changes were 5.63 ± 3.15 ng/L/g in SCS and 3.10 ± 1.83 ng/L/g in HMP (p = 0.150). HMP showed a lower increase in myocardial injury. These findings suggest the potential of HMP preservation system to prolong the safe ischemic time beyond the 4 hours limitation of SCS.
AB - Effective heart preservation is a critical determinant of transplant success. However, current techniques limit the allowable ischemic interval to four hours. A novel ex vivo continuous hypothermic cardiac preservation machine was developed at Mahidol University. This study evaluates the unoxygenated hypothermic machine perfusion (HMP) method by examining cardiac troponin I (cTnI) release as a marker of myocardial injury. Ten slaughterhouse porcine hearts—representing a donor after circulatory death (DCD) model—were randomized to Static Cold Storage (SCS) or HMP (n = 5/group). An in-house Histidine-Tryptophan-Ketoglutarate (HTK) solution served as both cardioplegic agent and perfusate. SCS followed gold-standard protocol, while HMP involved continuous retrograde perfusion at 13 mmHg; both groups were preserved under cold ischemic preservation at 4 degrees Celsius. Perfusate samples were collected at 0, 1, 2, 3, and 4 hours, and cTnI values were normalized to heart weight (cTnI/W). A mixed-effects model was used to analyze temporal changes. Final cTnI/W changes were 5.63 ± 3.15 ng/L/g in SCS and 3.10 ± 1.83 ng/L/g in HMP (p = 0.150). HMP showed a lower increase in myocardial injury. These findings suggest the potential of HMP preservation system to prolong the safe ischemic time beyond the 4 hours limitation of SCS.
KW - Cardiac Troponin I (cTnI)
KW - Donor after circulatory death (DCD)
KW - HTK solution
KW - Hypothermic machine perfusion (HMP)
KW - Myocardial injury
KW - Static cold storage (SCS)
UR - https://www.scopus.com/pages/publications/105048566104
U2 - 10.1007/978-3-032-20291-8_21
DO - 10.1007/978-3-032-20291-8_21
M3 - Conference contribution
AN - SCOPUS:105048566104
SN - 9783032202901
T3 - IFMBE Proceedings
SP - 271
EP - 279
BT - Proceedings of IUPESM World Congress on Medical Physics and Biomedical Engineering XXVII - Biosignal Processing, Medical Devices and Technologies for Healthcare
A2 - Colyer, Christopher
A2 - Dell’Oro, Mikaela
A2 - Forster, Jake
A2 - Pope, Kenneth
A2 - Langman, Lynne
PB - Springer Science and Business Media Deutschland GmbH
T2 - 27th UPESM World Congress on Medical Physics and Biomedical Engineering, IUPESM WC 2025
Y2 - 29 September 2025 through 4 October 2025
ER -